Summary
The relationships between biological indicators and exposure or tissue burdens are determined by the pharmacokinetic behaviour of the chemical. They can be studied by pharmacokinetic models of various types. Simple pharmacokinetic models are used here to describe general relationships valid for large groups of chemicals or situations. Important parameters to consider are the half-life of the biological indicator, the individual variability and the exposure variability. Biological sampling strategies are presented for monitoring of groups of workers, or individual workers. For specific chemicals, mainly solvents, more elaborate models can be developed, i.e., physiologically-based pharmacokinetic models including physiological, metabolic and physico chemical parameters. Such models are useful to describe the influence of confounding factors. Physiologically-based pharmacokinetic models can also be developed for metals and metalloids. Antimony is presented here as an example. In conclusion, pharmacokinetic modeling brings much information on sampling time, sample size, limit values, effect of physical workload and of individual physiological parameters.
Article PDF
Similar content being viewed by others
References
American Conference of Governmental Industrial Hygienists (1991) Threshold limit values and biological exposure indices for 1991–1992. ACGIH Cincinnati OH
Bailly R, Lauwerys R, Buchet JP, Mahieu P, Konings J (1991) Experimental and human studies on antimony metabolism: their relevance for the biological monitoring of workers exposed to inorganic antimony. Br J Ind Med 48:93–97
Droz PO, Wu MM, Cumberland WG, Berode M (1989a) Variability in biological monitoring of solvent exposure. I Development of a population physiological model. Br J Ind Med 46:447–460
Droz PO, Wu MM, Cumberland WG (1989b) Variability in biological monitoring of solvent exposure. II Application of a population physiological model. Br J Ind Med 46:547558
Droz PO, Berode M, Wu MM (1991) Evaluation of concomitant biological and air monitoring results. Appl Occup Environ Hyg 6:465–474
Droz PO, Wu MM (1991) Biological sampling strategies. In: Exposure assessment for epidemiology and hazard control, pp. 251–270. Lewis Publishers, Chelsea MI
Fiserova-Bergerova V, Pierce JT, Droz PO (1990) Dermal absorption potential of industrial chemicals. Criteria for skin notation. Am J Ind Med 17:617–635
Hawkins NC, Landenberger BD (1991) Statistical control charts: a technique for analyzing industrial hygiene data. Appl Occup Environ Hyg 6:689–695
Leidel NA, Busch KA, Lynch JR (1977) Occupational exposure sampling strategy manual. DHEW-IEW (NIOSH) Publication No 77-173, US Government Printing Office, Washington DC
Phalen RF, Hinds WC, John W, Lioy PJ, Lippmann M, McCawley MA, Raab OG, Soderholm SC. Stuart BO (1986) Rational and recommendations for particle size-selective sampling in the workplace. Appl Ind Hyg 1:3–14
Rappaport SM (1991) Exposure assessment strategies. In: Exposure assessment for epidemiology and hazard control, pp. 219–249. Lewis Publishers, Chelsea MI
Rees PH, Kager PA, Keating MI, Hockmeyer WT (1980) Renal clearance of pentavalent antimony (Sodium stibogluconate). Lancet (August 2, 1980): 226–-229
Smith TJ (1985) Development and application of a model for estimating alveolar and interstitial dust levels. Ann Occup Hyg 29:495–516
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Droz, P.O. Pharmacokinetic modeling as a tool for biological monitoring. Int. Arch Occup Environ Heath 65 (Suppl 1), S53–S59 (1993). https://doi.org/10.1007/BF00381308
Issue Date:
DOI: https://doi.org/10.1007/BF00381308